Provided to more than a quarter of cancer patients, today’s targeted radiotherapy has come a long way from its experimental, and Nobel Prize winning, origins. When administering the treatment, shaping ...

MRI-guided radiotherapy systems offer the ability to visualize tumour targets and surrounding organs with high accuracy, with the potential to perform real-time treatment adaptation based on ...

Accuray Incorporated ARAY recently announced the availability of its InCise Multileaf Collimator (MLC) for the CyberKnife M6 System in international markets, where it has already been approved for ...

Accuray Incorporated (Nasdaq: ARAY) and Lancaster General Health announced today that the first commercially available InCise™ Multileaf Collimator (MLC) for the CyberKnife ® M6™ System has been ...

Accuray Incorporated (Nasdaq: ARAY) announced today that the InCise™ Multileaf Collimator (MLC) for the CyberKnife ® M6™ System will now be available outside the United States in markets where it is ...

Elekta, a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders, has received clearance to CE mark Agility, a revolutionary beam-shaping ...

A new study now reports that there is an alternative to the conventional CyberKnife treatment delivery system. This new technique uses a multileaf collimator (MLC) and can flexibly sculpt a single ...

The shape of things to come: LAP and OTH Amberg-Weiden are developing a next-generation drive and control unit that promises an order-of-magnitude improvement in the speed and precision of the MLC ...

Renowned radiosurgery systems maker, Accuray Incorporated (ARAY) recently received the U.S. Food and Drug Administration (“FDA”) 510(k) approval for its new Cybernife M6 Series. This innovative series ...

Modulated Electron Radiotherapy (MERT) techniques represent an evolution in radiotherapy that harnesses the unique properties of electron beams to achieve highly conformal dose distributions. By ...